Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center ...

While some mutations in the BRCA2 gene clearly indicate risks for breast and prostate cancer, thousands of less-common variations have confounded doctors and left anxious patients without guidance ...

Scientists have characterized the role of thousands of mutations in the BRCA2 cancer gene, findings that may help reassure ...

Apollo Hospitals offers a breast cancer risk assessment tool for Indian women to understand their risk and take proactive ...

One diagnosis of cancer in a family is heartbreaking, however it's another story for the Nolan sisters who have seen the ...

Findings from a multi-institutional, international study have significantly advanced the understanding of genetic alterations in the BRCA2 gene, a key player in hereditary cancer risk.

The researchers completed a comprehensive functional assessment of all possible variants within the crucial DNA-binding domain of BRCA2, resulting in the clinical classification of 91% of variants ...

Scientists have analyzed thousands of mutations in the BRCA2 cancer gene, offering crucial insights. This research could help mitigate patient concerns or guide tailored treatments. By utilizing ...

Linda Nolan has become the third of the four Nolan sisters to have died from cancer disease in the past two years ...

Get Instant Summarized Text (Gist) A comprehensive study has advanced the understanding of BRCA2 gene variants, crucial for assessing hereditary cancer risk. By functionally assessing nearly 7,000 ...

Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center ...

After Linda Nolan's tragic death at 65, the Nolan sisters' cancer 'curse' has been revisited, as well as their efforts to ...